Keywords: novartis, xolair, shows, results, children, swiss, drug

Novartis' Xolair shows results in children

Article | 13 October 2008

Print This

Swiss drug major Novartis presented data from a Phase III trial confirming its Xolair (omalizumab) treatment for allergic asthma in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in